BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

616 hedge funds and large institutions have $1.57B invested in Bristol-Myers Squibb Company Contingent Value Rights in 2019 Q4 according to their latest regulatory filings, with 616 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
616
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$48M
Puts
$8.03M
Net Calls
Net Calls Change

Top Buyers

1
+$150M
2
+$107M
3
+$91.4M
4
Viking Global Investors
Viking Global Investors
Connecticut
+$78.3M
5
ACM
Abrams Capital Management
Massachusetts
+$69.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
201
$304K
202
$304K
203
$304K
204
$301K
205
$300K
206
$291K
207
$286K
208
$285K
209
$278K
210
$276K
211
$275K
212
$274K
213
$273K
214
$271K
215
$268K
216
$268K
217
$263K
218
$261K
219
$260K
220
$254K
221
$250K
222
$246K
223
$238K
224
$231K
225
$223K
7 8
9
10 11